Article(id=1329830529748283999, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329830490300854592, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2023.08.007, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1660665600000, receivedDateStr=2022-08-17, revisedDate=1683734400000, revisedDateStr=2023-05-11, acceptedDate=null, acceptedDateStr=null, onlineDate=1794985905348, onlineDateStr=2026-11-18, pubDate=1691596800000, pubDateStr=2023-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794985905348, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794985905348, creator=13701087609, updateTime=1794985905348, updator=13701087609, issue=Issue{id=1329830490300854592, tenantId=1146029695717560320, journalId=1319690329412173987, year='2023', volume='44', issue='8', pageStart='767', pageEnd='890', issueExtLink='null', onlineDate='null', pubDate='1691596800000', pubDateStr='2023-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794985895943, creator='13701087609', updateTime=1794987961153, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839152994038236, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329830490300854592, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839152994038237, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329830490300854592, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=805, endPage=812, ext={EN=ArticleExt(id=1329830529928639072, articleId=1329830529748283999, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Loplatin regulates the mechanism of action of lung cancer cell A549 through PERK/eIF2α/ATF4/CHOP signaling pathway, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To investigate the effects of lobaplatin on proliferation, apoptosis and migration of lung cancer cell A549 by regulating protein kinase R-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2α(eIF2α)/activating transcription factor 4 (ATF4)/CCAAT/enhancer binding protein homologous protein (CHOP) signaling pathway.

Methods

A549 cells were divided into control group, lobaplatin group (12 μmol/L lobaplatin), PERK inhibition group (5 μmol/L GSK2606414) and lobaplatin (12 μmol/L)+PERK inhibition group (5 μmol/L GSK2606414). MTT method, Transwell experiment and flow cytometry were used to detect cell proliferation, migration, invasion, and apoptosis. Western blot was used to detect the protein levels of PERK/eIF2α/ATF4/CHOP signaling pathway.

Results

Compared with the control group, the absorbance value, cell migration number and invasion number in lobaplatin group were decreased at 24 h and 48 h, and the apoptosis rate, phosphrylated-PERK/PERK, phosphrylated-eIF2α/eIF2α, ATF4 and CHOP protein levels were increased (P<0.01). The absorbance value, cell migration number and invasion number in PERK inhibited group were increased at 24 h and 48 h, and the protein levels related to PERK/eIF2α/ATF4/CHOP signaling pathway were decreased (P<0.01). Compared with lobaplatin group, the proliferation, migration and invasion numbers of A549 cells in lobaplatin+PERK inhibitory group were increased, and the apoptosis rate and the protein levels of PERK/eIF2α/ATF4/CHOP signaling pathway were decreased (P<0.01).

Conclusion

Lobaplatin may inhibit the proliferation, migration and invasion of A549 cells and promote cell apoptosis by activating the PERK/eIF2α/ATF4/CHOP pathway.

, authors=Kai TONG1, Honglan LUO2, authorsList=Kai TONG, Honglan LUO, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329830530138354273, articleId=1329830529748283999, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=洛铂通过PERK/eIF2α/ATF4/CHOP信号通路调节肺癌细胞A549的作用机制, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

探讨洛铂通过调节蛋白激酶R样内质网激酶(protein kinase R-like endoplasmic reticulum kinase,PERK)/真核生物起始因子2α(eukaryotic initiation factor 2α,eIF2α)/活化转录因子4(activating transcription factor 4,ATF4)/CCAAT/增强子结合蛋白同源蛋白(enhancer-binding protein homologous protein,CHOP)信号通路对肺癌细胞A549增殖、凋亡、迁移的影响。

方法

将A549细胞分为对照组、洛铂组(12 μmol/L洛铂)、PERK抑制组(5 μmol/L GSK2606414)及洛铂(12 μmol/L)+PERK抑制组(5 μmol/L GSK2606414)。通过MTT法、Transwell实验及流式细胞术检测细胞增殖、迁移、侵袭及凋亡;蛋白质印迹法检测细胞PERK/eIF2α/ATF4/CHOP信号通路相关蛋白水平。

结果

与对照组比较,洛铂组细胞24及48 h的吸光度值、细胞迁移数和侵袭数均下降,细胞凋亡率、磷酸化PERK/PERK、磷酸化eIF2α/eIF2α、ATF4以及CHOP蛋白水平均升高(P<0.01),PERK抑制组细胞24及48 h的吸光度值、细胞迁移数和侵袭数均升高,PERK/eIF2α/ATF4/CHOP信号通路相关蛋白水平降低(P<0.01)。与洛铂组比较,洛铂+PERK抑制组A549细胞增殖、迁移数以及侵袭数均升高,细胞凋亡率、PERK/eIF2α/ATF4/CHOP信号通路相关蛋白水平均下降(P<0.01)。

结论

洛铂可能通过激活PERK/eIF2α/ATF4/CHOP通路抑制A549细胞增殖、迁移以及侵袭,促进其凋亡。

, authors=童凯1, 罗红兰2, authorsList=童凯, 罗红兰, authorCompany=null, correspAuthors=null, authorNote=

童凯,主治医师,研究方向:呼吸与危重症医学方向。

, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=8Xa8m2IfqwluWGFCMrUYtQ==, magXml=E1fZ7vbLh7AK+CrQIcQwwQ==, pdfUrl=null, pdf=sn8IWFxbkAbXbSinRfvElA==, pdfFileSize=3443965, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=wSUo3gILZiAeAUciAHhy8w==, mapNumber=null, fund=null)}, authors=[Author(id=1329830533779010153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329830533858701931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830533779010153, language=EN, stringName=Kai TONG, firstName=Kai, middleName=null, lastName=TONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Respiratory and Critical Care medicine, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329830533955170924, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830533779010153, language=CN, stringName=童凯, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021, bio={"content":"

童凯,主治医师,研究方向:呼吸与危重症医学方向。

"}, bioImg=null, bioContent=

童凯,主治医师,研究方向:呼吸与危重症医学方向。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329830530394206818, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, xref=1., ext=[AuthorCompanyExt(id=1329830530406789731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830530394206818, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Respiratory and Critical Care medicine, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China), AuthorCompanyExt(id=1329830530415178340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830530394206818, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021)])]), Author(id=1329830534055834222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329830534206829168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830534055834222, language=EN, stringName=Honglan LUO, firstName=Honglan, middleName=null, lastName=LUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Oncology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329830534286520945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830534055834222, language=CN, stringName=罗红兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329830533695124069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, xref=2., ext=[AuthorCompanyExt(id=1329830533703512678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830533695124069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China), AuthorCompanyExt(id=1329830533707706983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830533695124069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021)])])], keywords=[Keyword(id=1329830534370407026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=EN, orderNo=1, keyword=lobaplatin), Keyword(id=1329830534437515891, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=EN, orderNo=2, keyword=protein kinase R-like endoplasmic reticulum kinase), Keyword(id=1329830534504624756, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=EN, orderNo=3, keyword=eukaryotic initiation factor 2α), Keyword(id=1329830534580122229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=EN, orderNo=4, keyword=activating transcription factor 4), Keyword(id=1329830534638842486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=EN, orderNo=5, keyword=enhancer-binding protein homologous protein), Keyword(id=1329830534705951351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=EN, orderNo=6, keyword=lung cancer), Keyword(id=1329830534768865912, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=CN, orderNo=1, keyword=洛铂), Keyword(id=1329830534819197561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=CN, orderNo=2, keyword=蛋白激酶R样内质网激酶), Keyword(id=1329830534873723514, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=CN, orderNo=3, keyword=真核生物起始因子2α), Keyword(id=1329830534949220987, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=CN, orderNo=4, keyword=活化转录因子4), Keyword(id=1329830535016329852, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=CN, orderNo=5, keyword=增强子结合蛋白同源蛋白), Keyword(id=1329830535091827325, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, language=CN, orderNo=6, keyword=肺癌)], refs=[Reference(id=1329830535192490622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Schabath MB, Cote ML. Cancer progress and priorities: lung cancer[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(10): 1563-1579., articleTitle=null, refAbstract=null), Reference(id=1329830535284765311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang C, Ma L, Niu Y, et al. Circular RNA in lung cancer research: biogenesis, functions, and roles[J]. Int J Biol Sci, 2020, 16(5): 803-814., articleTitle=null, refAbstract=null), Reference(id=1329830535356068480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Cao H, Feng Y, Chen L, et al. Lobaplatin inhibits prostate cancer proliferation and migration through regulation of BCL2 and BAX[J]. Dose Response, 2019, 17(2): 1559325819850981., articleTitle=null, refAbstract=null), Reference(id=1329830535448343169, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Ma D, Li S, Cui Y, et al. Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway[J]. Oncol Lett, 2021, 21(3): 219., articleTitle=null, refAbstract=null), Reference(id=1329830535523840642, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Chen Z, Xu G, Wu D, et al. Lobaplatin induces pyroptosis through regulating cIAP1/2, ripoptosome and ROS in nasopharyngeal carcinoma[J]. Biochem Pharmacol, 2020, 177: 114023., articleTitle=null, refAbstract=null), Reference(id=1329830535595143811, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Oakes SA. Endoplasmic reticulum stress signaling in cancer cells[J]. Am J Pathol, 2020, 190(5): 934-946., articleTitle=null, refAbstract=null), Reference(id=1329830535666446980, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Tang Z, Du W, Xu F, et al. Icariside Ⅱ enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells[J]. Int J Biol Sci, 2022, 18(5): 2060-2074., articleTitle=null, refAbstract=null), Reference(id=1329830537293836935, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang H, Chen R, Wang X, et al. Lobaplatin-induced apoptosis requires p53-mediated p38MAPK activation through ROS generation in non-small-cell lung cancer[J]. Front Oncol, 2019, 9: 538., articleTitle=null, refAbstract=null), Reference(id=1329830537365140104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Rahal Z, El Nemr S, Sinjab A, et al. Smoking and lung cancer: a geo-regional perspective[J]. Front Oncol, 2017, 7: 194., articleTitle=null, refAbstract=null), Reference(id=1329830537432248969, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Wadowska K, Bil-Lula I, Trembecki Ł, et al. Genetic markers in lung cancer diagnosis: a review[J]. Int J Mol Sci, 2020, 21(13): 4569., articleTitle=null, refAbstract=null), Reference(id=1329830537511940746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Yin Q, Han Y, ZHU D, et al. miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of nonsmall cell lung cancer by targeting MTDH[J]. Cancer Cell Int, 2018, 18: 105., articleTitle=null, refAbstract=null), Reference(id=1329830537625186955, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=王芮, 王义俊. 两种评估方法探究洛铂对老年肿瘤患者肾功能的影响[J]. 中国药师, 2022, 25(9): 1593-1597., articleTitle=null, refAbstract=null), Reference(id=1329830537709073036, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Lv Y, Xu A, Wang N, et al. Retrospective study of TACE in the treatment of lobaplatin-induced thrombocytopenia in primary hepatocellular carcinoma[J]. J BUON, 2019, 24(6): 2385-2393., articleTitle=null, refAbstract=null), Reference(id=1329830537780376205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=李莹莹, 詹丽芬, 曾哲超, 等. 洛铂对肝癌HepG2细胞增殖和调亡的作用及机制[J]. 临床肝胆病杂志, 2018, 34(4): 784-788., articleTitle=null, refAbstract=null), Reference(id=1329830537839096463, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhou NN, Zhao YY, Zhai LZ, et al. The efficacy and toxicity of lobaplatin-contained chemotherapy in extensive-stage small-cell lung cancer[J]. J Cancer, 2018, 9(13): 2232-2236., articleTitle=null, refAbstract=null), Reference(id=1329830537906205328, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Lin Y, Jiang M, Chen W, et al. Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response[J]. Biomed Pharmacother, 2019, 118: 109249., articleTitle=null, refAbstract=null), Reference(id=1329830537994285713, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Rozpedek W, Pytel D, Mucha B, et al. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress[J]. Curr Mol Med, 2016, 16(6): 533-544., articleTitle=null, refAbstract=null), Reference(id=1329830538061394578, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu X, Chen Y, Wang H, et al. Microglia-derived IL-1β promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK/eIF2α/ATF4/CHOP upon arsenic exposure[J]. J Hazard Mater, 2021, 417: 125997., articleTitle=null, refAbstract=null), Reference(id=1329830538132697747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Guo Y, Guo R, Su Y, et al. The PERK/eIF2α/ATF4/CHOP pathway plays a role in regulating monocrotaline-induced endoplasmic reticulum stress in rat liver[J]. Res Vet Sci, 2020, 130: 237-239., articleTitle=null, refAbstract=null), Reference(id=1329830538204000916, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Tsai TC, Lai KH, Su JH, et al. 7-acetylsinumaximol b induces apoptosis and autophagy in human gastric carcinoma cells through mitochondria dysfunction and activation of the PERK/eIF2α/ATF4/CHOP signaling pathway[J]. Mar Drugs, 2018, 16(4): 104., articleTitle=null, refAbstract=null), Reference(id=1329830538287886997, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Li J, Zhou JY, Zhou W, et al. Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway[J]. Am J Transl Res, 2020, 12(6): 2875-2889., articleTitle=null, refAbstract=null), Reference(id=1329830538359190166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Li D, Wang WJ, Wang YZ, et al. Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway[J]. Cell Death Dis, 2019, 10(10): 744., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329830530394206818, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, xref=1., ext=[AuthorCompanyExt(id=1329830530406789731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830530394206818, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Respiratory and Critical Care medicine, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China), AuthorCompanyExt(id=1329830530415178340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830530394206818, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021)]), AuthorCompany(id=1329830533695124069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, xref=2., ext=[AuthorCompanyExt(id=1329830533703512678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830533695124069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China), AuthorCompanyExt(id=1329830533707706983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830533695124069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.08.007, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.08.007, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2023.08.007, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2023.08.007, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1691596800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
洛铂通过PERK/eIF2α/ATF4/CHOP信号通路调节肺癌细胞A549的作用机制
童凯 1 , 罗红兰 2
世界临床药物 | 研究论文 2023,44(8): 805-812
收起
收藏切换
世界临床药物 |研究论文 2023 , 44 (8) : 805 -812
洛铂通过PERK/eIF2α/ATF4/CHOP信号通路调节肺癌细胞A549的作用机制
全屏
[Author(id=1329830533779010153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329830533858701931, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830533779010153, language=EN, stringName=Kai TONG, firstName=Kai, middleName=null, lastName=TONG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Respiratory and Critical Care medicine, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329830533955170924, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830533779010153, language=CN, stringName=童凯, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021, bio={"content":"

童凯,主治医师,研究方向:呼吸与危重症医学方向。

"}, bioImg=null, bioContent=

童凯,主治医师,研究方向:呼吸与危重症医学方向。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329830530394206818, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, xref=1., ext=[AuthorCompanyExt(id=1329830530406789731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830530394206818, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Respiratory and Critical Care medicine, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China), AuthorCompanyExt(id=1329830530415178340, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830530394206818, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021)])]), Author(id=1329830534055834222, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329830534206829168, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830534055834222, language=EN, stringName=Honglan LUO, firstName=Honglan, middleName=null, lastName=LUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.Department of Oncology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329830534286520945, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, authorId=1329830534055834222, language=CN, stringName=罗红兰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, address=2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329830533695124069, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, xref=2., ext=[AuthorCompanyExt(id=1329830533703512678, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830533695124069, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China), AuthorCompanyExt(id=1329830533707706983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329830529748283999, companyId=1329830533695124069, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021)])])]
童凯1, 罗红兰2
作者信息
  • 1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021
  • 2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021
作者简介:

童凯,主治医师,研究方向:呼吸与危重症医学方向。

Loplatin regulates the mechanism of action of lung cancer cell A549 through PERK/eIF2α/ATF4/CHOP signaling pathway
Kai TONG1, Honglan LUO2
Affiliations
  • 1.Department of Respiratory and Critical Care medicine, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China
  • 2.Department of Oncology, Huanggang Central Hospital Affiliated to Yangtze University, Huanggang 438021, Hubei Province, China
出版时间: 2023-08-10 doi: 10.13683/j.wph.2023.08.007
文章导航
收藏切换
目的

探讨洛铂通过调节蛋白激酶R样内质网激酶(protein kinase R-like endoplasmic reticulum kinase,PERK)/真核生物起始因子2α(eukaryotic initiation factor 2α,eIF2α)/活化转录因子4(activating transcription factor 4,ATF4)/CCAAT/增强子结合蛋白同源蛋白(enhancer-binding protein homologous protein,CHOP)信号通路对肺癌细胞A549增殖、凋亡、迁移的影响。

方法

将A549细胞分为对照组、洛铂组(12 μmol/L洛铂)、PERK抑制组(5 μmol/L GSK2606414)及洛铂(12 μmol/L)+PERK抑制组(5 μmol/L GSK2606414)。通过MTT法、Transwell实验及流式细胞术检测细胞增殖、迁移、侵袭及凋亡;蛋白质印迹法检测细胞PERK/eIF2α/ATF4/CHOP信号通路相关蛋白水平。

结果

与对照组比较,洛铂组细胞24及48 h的吸光度值、细胞迁移数和侵袭数均下降,细胞凋亡率、磷酸化PERK/PERK、磷酸化eIF2α/eIF2α、ATF4以及CHOP蛋白水平均升高(P<0.01),PERK抑制组细胞24及48 h的吸光度值、细胞迁移数和侵袭数均升高,PERK/eIF2α/ATF4/CHOP信号通路相关蛋白水平降低(P<0.01)。与洛铂组比较,洛铂+PERK抑制组A549细胞增殖、迁移数以及侵袭数均升高,细胞凋亡率、PERK/eIF2α/ATF4/CHOP信号通路相关蛋白水平均下降(P<0.01)。

结论

洛铂可能通过激活PERK/eIF2α/ATF4/CHOP通路抑制A549细胞增殖、迁移以及侵袭,促进其凋亡。

洛铂  /  蛋白激酶R样内质网激酶  /  真核生物起始因子2α  /  活化转录因子4  /  增强子结合蛋白同源蛋白  /  肺癌
Objective

To investigate the effects of lobaplatin on proliferation, apoptosis and migration of lung cancer cell A549 by regulating protein kinase R-like endoplasmic reticulum kinase (PERK)/eukaryotic initiation factor 2α(eIF2α)/activating transcription factor 4 (ATF4)/CCAAT/enhancer binding protein homologous protein (CHOP) signaling pathway.

Methods

A549 cells were divided into control group, lobaplatin group (12 μmol/L lobaplatin), PERK inhibition group (5 μmol/L GSK2606414) and lobaplatin (12 μmol/L)+PERK inhibition group (5 μmol/L GSK2606414). MTT method, Transwell experiment and flow cytometry were used to detect cell proliferation, migration, invasion, and apoptosis. Western blot was used to detect the protein levels of PERK/eIF2α/ATF4/CHOP signaling pathway.

Results

Compared with the control group, the absorbance value, cell migration number and invasion number in lobaplatin group were decreased at 24 h and 48 h, and the apoptosis rate, phosphrylated-PERK/PERK, phosphrylated-eIF2α/eIF2α, ATF4 and CHOP protein levels were increased (P<0.01). The absorbance value, cell migration number and invasion number in PERK inhibited group were increased at 24 h and 48 h, and the protein levels related to PERK/eIF2α/ATF4/CHOP signaling pathway were decreased (P<0.01). Compared with lobaplatin group, the proliferation, migration and invasion numbers of A549 cells in lobaplatin+PERK inhibitory group were increased, and the apoptosis rate and the protein levels of PERK/eIF2α/ATF4/CHOP signaling pathway were decreased (P<0.01).

Conclusion

Lobaplatin may inhibit the proliferation, migration and invasion of A549 cells and promote cell apoptosis by activating the PERK/eIF2α/ATF4/CHOP pathway.

lobaplatin  /  protein kinase R-like endoplasmic reticulum kinase  /  eukaryotic initiation factor 2α  /  activating transcription factor 4  /  enhancer-binding protein homologous protein  /  lung cancer
童凯, 罗红兰. 洛铂通过PERK/eIF2α/ATF4/CHOP信号通路调节肺癌细胞A549的作用机制. 世界临床药物, 2023 , 44 (8) : 805 -812 . DOI: 10.13683/j.wph.2023.08.007
Kai TONG, Honglan LUO. Loplatin regulates the mechanism of action of lung cancer cell A549 through PERK/eIF2α/ATF4/CHOP signaling pathway[J]. World Clinical Drug, 2023 , 44 (8) : 805 -812 . DOI: 10.13683/j.wph.2023.08.007

参考文献 引证文献
排序方式:
[1]
Schabath MB, Cote ML. Cancer progress and priorities: lung cancer[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(10): 1563-1579.
[2]
Zhang C, Ma L, Niu Y, et al. Circular RNA in lung cancer research: biogenesis, functions, and roles[J]. Int J Biol Sci, 2020, 16(5): 803-814.
[3]
Cao H, Feng Y, Chen L, et al. Lobaplatin inhibits prostate cancer proliferation and migration through regulation of BCL2 and BAX[J]. Dose Response, 2019, 17(2): 1559325819850981.
[4]
Ma D, Li S, Cui Y, et al. Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway[J]. Oncol Lett, 2021, 21(3): 219.
[5]
Chen Z, Xu G, Wu D, et al. Lobaplatin induces pyroptosis through regulating cIAP1/2, ripoptosome and ROS in nasopharyngeal carcinoma[J]. Biochem Pharmacol, 2020, 177: 114023.
[6]
Oakes SA. Endoplasmic reticulum stress signaling in cancer cells[J]. Am J Pathol, 2020, 190(5): 934-946.
[7]
Tang Z, Du W, Xu F, et al. Icariside Ⅱ enhances cisplatin-induced apoptosis by promoting endoplasmic reticulum stress signalling in non-small cell lung cancer cells[J]. Int J Biol Sci, 2022, 18(5): 2060-2074.
[8]
Zhang H, Chen R, Wang X, et al. Lobaplatin-induced apoptosis requires p53-mediated p38MAPK activation through ROS generation in non-small-cell lung cancer[J]. Front Oncol, 2019, 9: 538.
[9]
Rahal Z, El Nemr S, Sinjab A, et al. Smoking and lung cancer: a geo-regional perspective[J]. Front Oncol, 2017, 7: 194.
[10]
Wadowska K, Bil-Lula I, Trembecki Ł, et al. Genetic markers in lung cancer diagnosis: a review[J]. Int J Mol Sci, 2020, 21(13): 4569.
[11]
Yin Q, Han Y, ZHU D, et al. miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of nonsmall cell lung cancer by targeting MTDH[J]. Cancer Cell Int, 2018, 18: 105.
[12]
王芮, 王义俊. 两种评估方法探究洛铂对老年肿瘤患者肾功能的影响[J]. 中国药师, 2022, 25(9): 1593-1597.
[13]
Lv Y, Xu A, Wang N, et al. Retrospective study of TACE in the treatment of lobaplatin-induced thrombocytopenia in primary hepatocellular carcinoma[J]. J BUON, 2019, 24(6): 2385-2393.
[14]
李莹莹, 詹丽芬, 曾哲超, 等. 洛铂对肝癌HepG2细胞增殖和调亡的作用及机制[J]. 临床肝胆病杂志, 2018, 34(4): 784-788.
[15]
Zhou NN, Zhao YY, Zhai LZ, et al. The efficacy and toxicity of lobaplatin-contained chemotherapy in extensive-stage small-cell lung cancer[J]. J Cancer, 2018, 9(13): 2232-2236.
[16]
Lin Y, Jiang M, Chen W, et al. Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response[J]. Biomed Pharmacother, 2019, 118: 109249.
[17]
Rozpedek W, Pytel D, Mucha B, et al. The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress[J]. Curr Mol Med, 2016, 16(6): 533-544.
[18]
Liu X, Chen Y, Wang H, et al. Microglia-derived IL-1β promoted neuronal apoptosis through ER stress-mediated signaling pathway PERK/eIF2α/ATF4/CHOP upon arsenic exposure[J]. J Hazard Mater, 2021, 417: 125997.
[19]
Guo Y, Guo R, Su Y, et al. The PERK/eIF2α/ATF4/CHOP pathway plays a role in regulating monocrotaline-induced endoplasmic reticulum stress in rat liver[J]. Res Vet Sci, 2020, 130: 237-239.
[20]
Tsai TC, Lai KH, Su JH, et al. 7-acetylsinumaximol b induces apoptosis and autophagy in human gastric carcinoma cells through mitochondria dysfunction and activation of the PERK/eIF2α/ATF4/CHOP signaling pathway[J]. Mar Drugs, 2018, 16(4): 104.
[21]
Li J, Zhou JY, Zhou W, et al. Endoplasmic reticulum stress triggers delanzomib-induced apoptosis in HCC cells through the PERK/eIF2α/ATF4/CHOP pathway[J]. Am J Transl Res, 2020, 12(6): 2875-2889.
[22]
Li D, Wang WJ, Wang YZ, et al. Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway[J]. Cell Death Dis, 2019, 10(10): 744.
2023年第44卷第8期
15
3
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2023.08.007
  • 接收时间:2022-08-17
  • 首发时间:2026-11-18
  • 出版时间:2023-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-08-17
  • 修回日期:2023-05-11
基金
作者信息
    1.长江大学附属黄冈市中心医院呼吸与危重症医学科,湖北 黄冈 438021
    2.长江大学附属黄冈市中心医院肿瘤内科,湖北 黄冈 438021
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2023.08.007
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏